Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cartesian Therapeutics, Inc. Director's Dealing 2024

Nov 22, 2024

33483_dirs_2024-11-21_348af524-f6a0-475a-b03d-53326160c710.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cartesian Therapeutics, Inc. (RNAC)
CIK: 0001453687
Period of Report: 2024-11-19

Reporting Person: Singer Michael (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-19 Common Stock G 28821 Disposed 90933 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 383796 Indirect
Common Stock 56719 Indirect
Common Stock 7127 Indirect
Common Stock 14788 Indirect
Common Stock 96219 Indirect
Common Stock 96219 Indirect

Footnotes

F1: Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of this trust.

F2: Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of this trust.

F3: Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of this trust.

F4: Shares are held by the reporting person's spouse.

F5: The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian.

F6: The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.